Neurocrine Biosciences
NBIX
#1345
Rank
C$23.46 B
Marketcap
C$233.41
Share price
1.78%
Change (1 day)
36.50%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Stock price history for Neurocrine Biosciences (NBIX)

Highest end of day price: C$229.32 CAD on 2026-06-03

Lowest end of day price: C$2.78 CAD on 2009-11-12

Stock price history of Neurocrine Biosciences from 1996 to 2026

Annual Stock Price Performance

Year Performance
2026 16.41%
2025 2.88%
2024 3.62%
2023 9.73%
2022 35.01%
2021-11.16%
2020-11.50%
2019 53.36%
2018-9.95%
2017 100.70%
2016-26.07%
2015 147.68%
2014 133.93%
2013 14.74%
2012-12.51%
2011 10.82%
2010 184.01%
2009-16.82%
2008-29.20%
2007-55.79%
2006-83.61%
2005 27.97%
2004-11.17%
2003 20.11%
2002-9.71%
2001 59.41%
2000 31.84%
1999 260.00%
1998-17.29%
1997-17.65%
1996-20.00%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
C$35.69 1.41%๐Ÿ‡บ๐Ÿ‡ธ USA
C$310.23 2.87%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1,576 5.18%๐Ÿ‡บ๐Ÿ‡ธ USA
C$175.31 3.69%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.01875-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
C$107.90 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
C$19.58 4.44%๐Ÿ‡บ๐Ÿ‡ธ USA
C$76.83 0.64%๐Ÿ‡ฌ๐Ÿ‡ง UK